Registered nurse Christine Keller sits down with Dr Jacques van Staden to cut through the hype on Ozempic (semaglutide), tirzepatide, and other GLP-1 weight-loss injections. If you’ve wondered whether these meds are safe, who they’re really for, or how they fit into type 1 vs type 2 diabetes care, this episode gives you clear, evidence-based answers.What you’ll learn:•⁠ ⁠How GLP-1/GIP drugs work (beyond weight loss)•⁠ ⁠Real benefits vs risks & side effects (nausea, pancreatitis, eye concerns, sarcopenia)•⁠ ⁠Why these meds were designed for type 2 diabetes,not type 1•⁠ ⁠The truth about micro-dosing, counterfeit pens & safety•⁠ ⁠Menopause, metabolism, and why strength training + protein matter•⁠ ⁠Practical questions to ask before starting treatmentIf you’re considering Ozempic/semaglutide/tirzepatide or support someone with diabetes, this conversation is for you.Subscribe for science-backed skin, health & metabolic insights.

Ver todos los episodios